Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS · Delayed Price · Currency is USD
0.0802
-0.0028 (-3.40%)
At close: Feb 11, 2026

KBLB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
3.212.912.381.942.564.45
Research & Development
0.160.160.240.180.20.09
Operating Expenses
3.373.072.612.122.764.53
Operating Income
-3.37-3.07-2.61-2.12-2.76-4.53
Interest Expense
-0.56-0.53-0.48-1.72-5.36-0.39
Interest & Investment Income
0.010.070.11---
Other Non Operating Income (Expenses)
------0.05
EBT Excluding Unusual Items
-3.92-3.53-2.99-3.84-8.12-4.97
Gain (Loss) on Sale of Investments
0.230.130.060-0.01-
Asset Writedown
---0.1---
Other Unusual Items
----0.09-
Pretax Income
-3.69-3.4-3.03-3.84-8.05-4.97
Net Income
-3.69-3.4-3.03-3.84-8.05-4.97
Net Income to Common
-3.69-3.4-3.03-3.84-8.05-4.97
Shares Outstanding (Basic)
1,0491,0381,033974878849
Shares Outstanding (Diluted)
1,0491,0381,033974878849
Shares Change (YoY)
1.14%0.51%6.04%11.02%3.41%1.56%
EPS (Basic)
-0.00-0.00-0.00-0.00-0.01-0.01
EPS (Diluted)
-0.00-0.00-0.00-0.00-0.01-0.01
Free Cash Flow
-1.86-1.84-1.25-1.89-1.9-1.25
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00-0.00
EBITDA
-3.34-3.05-2.59-2.09-2.73-4.51
D&A For EBITDA
0.020.030.030.030.030.03
EBIT
-3.37-3.07-2.61-2.12-2.76-4.53
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.